Key result
Early-manifesting female heterozygotes with Duchenne or Becker muscular dystrophy exhibited high rates of intellectual disability (77.8%) and mental health disorders (55.6%).
Observational (n=9)
Yes
Early-manifesting female heterozygotes with Duchenne or Becker muscular dystrophy exhibit a high frequency of intellectual and mental health problems, highlighting the need for comprehensive health supervision.
Manifesting female DMD/BMD carriers may warrant neurodevelopmental screening; case reports leave open controlled comparisons to non-manifesting heterozygotes.
Manifestations of Duchenne and Becker muscular dystrophy (DBMD) are present in up to 40% of heterozygous females, but there are few reports of females who exhibit skeletal muscle symptoms in childhood. From the Muscular Dystrophy Surveillance Tracking and Research Network, a multi-site population-based surveillance network for dystrophinopathy, nine symptomatic female heterozygotes with onset of symptoms prior to age 9 years were identified. The median age at diagnosis was 8.3 years, and the median interval from first symptoms to diagnosis was 1.35 years. Of the nine female heterozygotes, four had a positive family history, seven had intellectual disability and five had at least one mental health disorder. Mental health concerns included attention deficit hyperactivity disorder (ADHD), autism spectrum features, bipolar disorder, and depression. The frequency of intellectual and mental health problems in this group is higher than previously reported for affected males and for symptomatic females. These findings may have implications for diagnosis of early manifesting heterozygotes and for their health supervision.
No takes yet. Share an insight, caveat, or question.
Imbornoni et al. (2014) conducted an observational in Duchenne or Becker muscular dystrophy (n=9). Heterozygous Duchenne or Becker muscular dystrophy was evaluated on Intellectual disability. Early-manifesting female heterozygotes with Duchenne or Becker muscular dystrophy exhibited high rates of intellectual disability (77.8%) and mental health disorders (55.6%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: